Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche

H Ye, B Adane, N Khan, T Sullivan, M Minhajuddin… - Cell stem cell, 2016 - cell.com
H Ye, B Adane, N Khan, T Sullivan, M Minhajuddin, M Gasparetto, B Stevens, S Pei, M Balys…
Cell stem cell, 2016cell.com
Adipose tissue (AT) has previously been identified as an extra-medullary reservoir for
normal hematopoietic stem cells (HSCs) and may promote tumor development. Here, we
show that a subpopulation of leukemic stem cells (LSCs) can utilize gonadal adipose tissue
(GAT) as a niche to support their metabolism and evade chemotherapy. In a mouse model of
blast crisis chronic myeloid leukemia (CML), adipose-resident LSCs exhibit a pro-
inflammatory phenotype and induce lipolysis in GAT. GAT lipolysis fuels fatty acid oxidation …
Summary
Adipose tissue (AT) has previously been identified as an extra-medullary reservoir for normal hematopoietic stem cells (HSCs) and may promote tumor development. Here, we show that a subpopulation of leukemic stem cells (LSCs) can utilize gonadal adipose tissue (GAT) as a niche to support their metabolism and evade chemotherapy. In a mouse model of blast crisis chronic myeloid leukemia (CML), adipose-resident LSCs exhibit a pro-inflammatory phenotype and induce lipolysis in GAT. GAT lipolysis fuels fatty acid oxidation in LSCs, especially within a subpopulation expressing the fatty acid transporter CD36. CD36+ LSCs have unique metabolic properties, are strikingly enriched in AT, and are protected from chemotherapy by the GAT microenvironment. CD36 also marks a fraction of human blast crisis CML and acute myeloid leukemia (AML) cells with similar biological properties. These findings suggest striking interplay between leukemic cells and AT to create a unique microenvironment that supports the metabolic demands and survival of a distinct LSC subpopulation.
cell.com